- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02861508
Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department
27 février 2020 mis à jour par: Yale University
The purpose of the proposed research is to examine whether incorporating point-of-care ultrasound (POCUS) early in diagnostic work-up of cardiopulmonary complaints will affect diagnosis, time to condition-specific intervention, and ultimately patient outcomes compared to usual care.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
170
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Connecticut
-
New Haven, Connecticut, États-Unis, 06510
- Yale New Haven Hospital
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Chief complaint of chest pain, dyspnea (either sudden onset or increased severity of chronic dyspnea), syncope, or hypotension (systolic blood pressure <100 or shock index [heart rate divided by systolic blood pressure] >1)
Exclusion Criteria:
- <18 years old
- Prisoner or ward of the state
- Trauma
- High acuity requiring treatment in resuscitation room
- Obvious cause of symptoms (e.g. acute GI bleed causing hypotension)
- Any form of "do not resuscitate" (DNR) order
- Roomed in hall of emergency department (location not amenable to ultrasound protocol)
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Usual care
Usual care as determined by treating team.
Ultrasound may still be part of the workup per the treating team's discretion.
|
|
|
Expérimental: Early POCUS
Point-of-care ultrasound protocol will involve cardiac views (for pericardial effusion, left ventricular function, left and right ventricular equality, aortic root dilation, and inferior vena cava status), lung views (for pneumothorax, signs of alveolar interstitial syndrome), abdominal views for free fluid, and a view of the abdominal aorta for aneurysm.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Time to appropriate intervention
Délai: Within 30 days of presentation
|
Based on final diagnosis as determined by final review of the patient's overall visit in the medical record, it will be determined what the appropriate intervention(s) that the patient should have received.
Subsequently, the amount of time that elapsed (minutes) between time the patient was roomed in the emergency department (ED) and time to when they received the intervention will be collected.
All these time points are readily available in the electronic medical record in the patient care timeline.
This outcome will help determine whether early POCUS affects how quickly patients receive appropriate intervention.
|
Within 30 days of presentation
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Diagnostic accuracy
Délai: Within 30 days of presentation
|
The treating team in the ED will be asked for their diagnostic impression of the patient's chief complaint at several points during the patient's time in the ED.
These points will be (1) after the primary provider's initial assessment, (2) at time of disposition, and (3) if they are in the early POCUS group, after the POCUS findings are relayed to them.
They will select their single most likely diagnosis each time, which will be compared against a final diagnosis as determined by final review of the patient's overall visit in the medical record (as this study's gold standard for diagnosis).
This outcome will examine how often (percentage-wise) the treating team's diagnosis matches the final diagnosis as well as if early POCUS has any impact on helping physicians reach the correct diagnosis.
|
Within 30 days of presentation
|
|
Diagnostic certainty
Délai: Within 2 days of presentation
|
Similar to the outcome of diagnostic accuracy, the treating team in the ED will concomitantly be asked how certain they feel about their diagnosis on a five-point scale.
The presence of any changes in certainty (i.e.
proportion of patients for whom certainty changed) as well as how much change (e.g.
increased certainty by 2 points) will be assessed.
This outcome will determine if early POCUS affects physicians' certainty of diagnosis.
|
Within 2 days of presentation
|
|
Time to disposition
Délai: Within 2 days of presentation
|
This will be measured as amount of time (in minutes) that elapse between the time patient is roomed in the ED to time the treating team determines patient disposition.
These timestamps are available in the medical record under the patient care timeline.
This outcome will examine if early POCUS affects the time it takes for the treatment team to achieve a disposition plan for the patient.
|
Within 2 days of presentation
|
|
Total length of stay
Délai: Within 30 days of presentation
|
This will be measured as time (in days) between the patient's date of presentation and date of discharge.
This outcome will examine if early POCUS affects the amount of time that patients stay in the hospital.
|
Within 30 days of presentation
|
|
30-day in-hospital mortality
Délai: Within 30 days of presentation
|
Patients will be followed in their medical record for up to 30 days after their initial presentation to assess for in-hospital mortality rate.
This outcome will examine if early POCUS leads to any significant difference in patient mortality rate compared to usual care.
|
Within 30 days of presentation
|
|
Duration of POCUS
Délai: Within 2 days of presentation
|
For the early POCUS group, this will be measured as the amount of time (in minutes) between the time the ultrasound is started and the time the last image is captured.
All images/video clips acquired by the ultrasound machine have a timestamp.
A blank image will be captured at the start of the exam for the initial timestamp.
This outcome will examine how time-consuming our POCUS exam is and provides a sense of how disruptive the introduction of POCUS might be if it were implemented routinely.
|
Within 2 days of presentation
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Return visits with missed diagnosis
Délai: Within 30 days of presentation
|
The patient's medical record will be followed for 30 days after initial presentation for the presence of any repeat visits with the healthcare system for a similar chief complaint.
If so, that repeat visit will be reviewed for the presence of a different diagnosis than that established at the original visit, which would suggest that the correct diagnosis had been missed at that time.
It will then be determined what the percentage of patients is with such visits out of all patients in the study.
This outcome will examine if POCUS helps with picking up diagnoses that might be missed otherwise.
|
Within 30 days of presentation
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Christopher Moore, MD, Yale University
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 juillet 2016
Achèvement primaire (Réel)
30 juin 2018
Achèvement de l'étude (Réel)
30 juin 2018
Dates d'inscription aux études
Première soumission
5 août 2016
Première soumission répondant aux critères de contrôle qualité
5 août 2016
Première publication (Estimation)
10 août 2016
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
28 février 2020
Dernière mise à jour soumise répondant aux critères de contrôle qualité
27 février 2020
Dernière vérification
1 février 2020
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Processus pathologiques
- Maladies cardiovasculaires
- Maladies vasculaires
- Maladies du système nerveux
- Maladies des voies respiratoires
- Troubles respiratoires
- La douleur
- Manifestations neurologiques
- Manifestations neurocomportementales
- Attributs de la maladie
- Signes et symptômes respiratoires
- Inconscience
- Troubles de la conscience
- Urgences
- Douleur thoracique
- Hypotension
- Syncope
- Dyspnée
Autres numéros d'identification d'étude
- 1605017729
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Non
Description du régime IPD
No specific plans for now but would be open to sharing anonymized data.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .